Publication: Insulin-like growth factor levels and chronic lymphocytic leukaemia: results from the MCC-Spain and EpiLymph-Spain studies.
dc.contributor.author | Casabonne, Delphine | |
dc.contributor.author | Benavente, Yolanda | |
dc.contributor.author | Costas, Laura | |
dc.contributor.author | Robles, Claudia | |
dc.contributor.author | Gonzalez-Barca, Eva | |
dc.contributor.author | de la Banda, Esmeralda | |
dc.contributor.author | Alonso, Esther | |
dc.contributor.author | Aymerich, Marta | |
dc.contributor.author | Campo, Elías | |
dc.contributor.author | Marcos-Gragera, Rafael | |
dc.contributor.author | Tardón, Adonina | |
dc.contributor.author | Olmedo-Requena, Rocío | |
dc.contributor.author | Gimeno, Eva | |
dc.contributor.author | Martínez-López, Alba | |
dc.contributor.author | Casanovas, Oriol | |
dc.contributor.author | Castaño-Vinyals, Gemma | |
dc.contributor.author | Aragonés, Nuria | |
dc.contributor.author | Pollán, Marina | |
dc.contributor.author | Kogevinas, Manolis | |
dc.contributor.author | de Sanjosé, Silvia | |
dc.date.accessioned | 2023-01-25T10:24:40Z | |
dc.date.available | 2023-01-25T10:24:40Z | |
dc.date.issued | 2018-11-19 | |
dc.identifier.doi | 10.1111/bjh.15583 | |
dc.identifier.essn | 1365-2141 | |
dc.identifier.pmid | 30450673 | |
dc.identifier.unpaywallURL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.15583 | |
dc.identifier.uri | http://hdl.handle.net/10668/13206 | |
dc.issue.number | 3 | |
dc.journal.title | British journal of haematology | |
dc.journal.titleabbreviation | Br J Haematol | |
dc.language.iso | en | |
dc.organization | Hospital Universitario San Cecilio | |
dc.page.number | 608-612 | |
dc.pubmedtype | Clinical Trial | |
dc.pubmedtype | Letter | |
dc.pubmedtype | Multicenter Study | |
dc.pubmedtype | Research Support, Non-U.S. Gov't | |
dc.rights.accessRights | open access | |
dc.subject | Chronic lymphocytic leukaemia | |
dc.subject | body mass index | |
dc.subject | insulin-like growth factor 1 | |
dc.subject | insulin-like growth factor binding protein 3 | |
dc.subject | plasma | |
dc.subject.mesh | Biomarkers, Tumor | |
dc.subject.mesh | Female | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Insulin-Like Growth Factor Binding Protein 3 | |
dc.subject.mesh | Insulin-Like Growth Factor I | |
dc.subject.mesh | Leukemia, Lymphocytic, Chronic, B-Cell | |
dc.subject.mesh | Male | |
dc.subject.mesh | Neoplasm Proteins | |
dc.subject.mesh | Spain | |
dc.title | Insulin-like growth factor levels and chronic lymphocytic leukaemia: results from the MCC-Spain and EpiLymph-Spain studies. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 185 | |
dspace.entity.type | Publication |